November 13, 2025 ⢠by Jim Pulcrano in Tech for Good
Matthew Lapinski, CEO of Clee Medical, shares how the Swiss startup is making brain surgery safer, faster, and more precise....
Brain surgery has always been a high-stakes gamble. Surgeons are hampered by a lack of data, relying on pre-operative scans and intuition when every millimeter matters.
Clee Medical plans to change that. The Swiss startup, co-founded by Matt Lapinski and Abed Hammoud (EMBA 2004), has developed real-time imaging and sensing technology that gives brain surgeons greater precision and visualization during operations.
āIf we can tell surgeons where they actually are [ā¦] brain surgery is much more efficient, there are better patient outcomes, unlocking new targets in the brain,ā explains Lapinski.
Watch Lapinski reveal what drives him, where Clee Medical stands in its development journey, the make-or-break challenges over the next 12-18 months, and his personal highs of the entrepreneurship journey.

CEO and Co-founder, Clee Medical
Matthew Lapinski is an engineer and leader, leveraging his experience in medical device development to lead Clee Medical. The company is developing the keys to a better understanding of the brain and shaping the future of neurotech through novel imaging, device design, and AI.

Adjunct Professor of Entrepreneurship and Management
Jim Pulcrano is an IMD Adjunct Professor of Entrepreneurship and Management. His current projects include teaching in Lausanne, London and Silicon Valley, research on disruption, and various strategy, networking, customer-centricity, and innovation mandates with multinationals in Europe, Asia, and the US. At IMD, He is Director of theĀ Venture Capital Asset Management (VCAM) program and teaches on theĀ Executive MBAĀ (EMBA),Ā Orchestrating Winning PerformanceĀ (OWP), and full-timeĀ MBAĀ programs.
Explore first person business intelligence from top minds curated for a global executive audience